1. Home
  2. AEMD vs BYAH Comparison

AEMD vs BYAH Comparison

Compare AEMD & BYAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aethlon Medical Inc.

AEMD

Aethlon Medical Inc.

HOLD

Current Price

$2.46

Market Cap

2.1M

Sector

Health Care

ML Signal

HOLD

Logo Park Ha Biological Technology Co. Ltd. Ordinary Shares

BYAH

Park Ha Biological Technology Co. Ltd. Ordinary Shares

HOLD

Current Price

$2.75

Market Cap

2.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEMD
BYAH
Founded
1984
2016
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.1M
2.3M
IPO Year
2008
2023

Fundamental Metrics

Financial Performance
Metric
AEMD
BYAH
Price
$2.46
$2.75
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
115.6K
1.0M
Earning Date
02-12-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.51
$0.05
52 Week High
$5.89
$6.64

Technical Indicators

Market Signals
Indicator
AEMD
BYAH
Relative Strength Index (RSI) 65.30 61.86
Support Level $2.00 $0.19
Resistance Level $3.11 $6.56
Average True Range (ATR) 0.22 0.31
MACD -0.08 -0.08
Stochastic Oscillator 87.36 16.39

Price Performance

Historical Comparison
AEMD
BYAH

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.

About BYAH Park Ha Biological Technology Co. Ltd. Ordinary Shares

Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.

Share on Social Networks: